Methods for treating ocular neovascular diseases
OwnerDavid R. Guyerinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy.
Claims49
A method for treating an ocular neovascular disease in a patient, said method comprising the steps of:
- (a) administering to said patient an effective amount of an anti-VEGF aptamer;
- and
- (b) providing said patient with phototherapy.
A method for treating an ocular neovascular disease in a patient, said method comprising administering to said patient:
- (a) an effective amount of an anti-VEGF aptamer;
- and
- (b) a second compound capable of diminishing or preventing the development of unwanted neovasculature.
A method for treating an ocular neovascular disease in a patient, said method comprising the steps of:
- (a) administering to said patient an effective amount of an anti-VEGF aptamer that inhibits the development of ocular neovascularization;
- and
- (b) providing said patient with a therapy that destroys abnormal blood vessels in the eye.
A method for treating an ocular neovascular disease in a patient, said method comprising administering to an eye of said patient between about 0.3 mg to about 3 mg of a modified nucleic acid ligand to VEGF.
Dependencies are inferred from the claim text.